The state of COVID-19 testing
In these unprecedented times, we know that controlling the spread of novel coronavirus requires social distancing and testing. While all of us are doing our parts to stay at home, there’s a lot of confusion, chaos and frustration surrounding coronavirus testing in the US. Before going further, I want to be clear that I am […]
Announcing the Version One Opportunity Fund
It has been almost 10 years since Union Square Ventures launched the first Opportunity Fund, creating a strategy that has since been copied by many other VC’s. An opportunity fund is basically a separate pool of capital that allows a VC to continue to invest in its most promising portfolio companies once the core funds […]
Regulatory arbitrage in crypto
Almost six years ago Marc Andreessen spelled out the playbook for creating the next Silicon Valley: Don’t copy the Valley but “figure out what domain is (or could be) specific to a specific region—and then removing the regulatory hurdles for that particular domain”. Unfortunately for the Valley (and North America in general), a few regions […]
Announcing our investment in Halcyon Health
Last week, I outlined our current areas of interest in healthcare: patient networks, digital therapeutics, patient care management, new diagnostics, and disrupting health insurance. At the same time, one of my closest friends, Josh Nussbaum, introduced his new company, Halcyon Health, to the world. I encourage everyone to read Josh’s own words about Halcyon and […]
Our areas of interest in healthcare
Over the past two weeks, Boris and Max have shared their investment themes and interests. Boris wrote about the latest opportunities in enterprise SaaS, while Max outlined some of his current investment themes, from the Open Internet to climate change. I’m going to continue the trend by highlighting some of the key areas in healthcare […]